Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $725.05M.
ENTERPRISE VALUE (EV)
$725.05M
Anteris Technologies Global Corp.
Market Cap
$737.02M
Enterprise Value (EV)
$725.05M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Anteris Technologies Global Corp. (AVR) | $737.02M | $725.05M |
| Achieve Life Sciences, Inc. (ACHV)vs › | $719.64M | $686.63M |
| Candel Therapeutics, Inc. (CADL)vs › | $749.55M | $597.51M |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.33M | $1.44B |
| Helus Pharma Inc. (HELP)vs › | $707.86M | $541.69M |
| Avalo Therapeutics, Inc. (AVTX)vs › | $767.46M | $682.32M |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | $672.29M |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.32M | $745.82M |
| Design Therapeutics, Inc. (DSGN)vs › | $775.72M | $764.84M |
| Geron Corporation (GERN)vs › | $776.24M | $835.74M |
Market Cap
$737.02M
Total Debt
$604000.00
Cash
$12.58M
Enterprise Value
$725.05M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
